Coronavirus irna compositions and methods of use thereof

TW202631997APending Publication Date: 2026-08-01ALNYLAM PHARMACEUTICALS INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2021-03-25
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001071884_001
    Figure TWG2TA001071884_001
  • Figure TWG2TA001071884_002
    Figure TWG2TA001071884_002
  • Figure TWG2TA001071884_003
    Figure TWG2TA001071884_003
Patent Text Reader

Abstract

The present invention relates to RNAi agents,e.g.,dsRNA agents, targeting the coronavirus genome. The invention also relates to methods of using such RNAi agents to inhibit expression of a coronavirus genome and to methods of treating or preventing a coronavirus-associated disease in a subject.
Need to check novelty before this filing date? Find Prior Art